| 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2024/6/27 | － | 2024/6/28 | 2024/6/28 | 差异化分红送转： 是 一、 通过分配方案的股东大会届次和日期 证券代码：600327 证券简称：大东方 公告编号：2024-019 无锡商业大厦大东方股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利 0.06 元 相关日期 本次利润分配方案经公司 2024 年 5 月 10 日的 2023 年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上市公司股份回购规则》、《上海证券交易所上市公司自律监管指引第 7 号——回 购股份》等相关法律、行政法规、部门规 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股票代码：600327 股票简称：大东方 公告编号：临 2024－018 无锡商业大厦大东方股份有限公司 2023 年度暨 2024 年第一季度业绩说明会预告公告 三、参加人员 董事长：林乃机 董事、总经理：席国良 董事会秘书：陈辉 财务总监：徐文武 独立董事：居晓林 会议召开时间：2024 年 5 月 28 日（星期二）上午 11:00-12:00 会议召开 地 点 ： 上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 5 月 21 日(星期二)至 5 月 27 日(星期一)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 cmc@eastall.com 进行提问。公司将在说明会上对投资者普遍关注的问 题进行回答。 四、投资者参加方式 无锡商业大厦大东方股份有限公司（以下简称"公司"）分别于 2024 年 4 月 20 日、20 ...

重要内容提示： (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会，由公司董事会九届二次会议决议召开，于 2024 年 4 月 20 日在《上 海证券报》及上海证券交易所网站发出召开会议通知的公告，于 2024 年 5 月 10 日以公司现场会议和网络投票结合方式召开。现场会议由林乃机董事长主持，会 议的召集、召开符合相关法律法规及公司章程的规定。 (五) 公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 无锡商业大厦大东方股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600327 证券简称：大东方 公告编号：2024-017 审议结果：通过 表决情况： | 股东 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | | 类型 | 票数 | 比例（%） | 票数 | 比例（%） | 票数 | 比例（%） | | A 股 | 397,046,664 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于无锡商业大厦大东方股份有限公司 2023 年年度股东大会的法律意见书 国枫律股字[2024]A0180 号 致：无锡商业大厦大东方股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2023 年年度股东大会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东大会规则》（以下简 称"《股东大会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券 法律业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证 券法律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《无锡商业大厦 大东方股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召 开程序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜 ...

无锡商业大厦大东方股份有限公司 2023 年年度股东大会资料 股票简称：大东方 股票代码：600327 二○二四年五月十日 股东大会会议须知 为维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，根据《公司法》、 《上市公司股东大会规则》及《公司章程》等相关规定，特制定本须知，请出席股东大 会的全体人员遵照执行。 一、本公司按照法律、法规、有关规定和《公司章程》等规定组织本次股东大会的 召开，并设立股东大会会务组具体安排本次股东大会各项事宜。 二、股东大会现场会议参会股东或股东代理人应根据《大东方关于召开2023年年度 股东大会的通知》（本公司于2024年4月20日在上海证券交易所网站www.sse.com.cn及上 海证券报的公告）的要求，在2024年5月8日10:00—16:00期间，提供身份证明、股票账 户卡、授权委托书等资料向公司董事会办公室办理参会登记。 三、为保证股东大会现场会议的严肃性和正常秩序，切实维护股东的合法权益，务 必请出席现场会议的股东或股东代理人按股东大会会议通知的要求携带参会资格登记资 料，提前到达会场登记参会资格并签到。未能提供有效参会资格登记资料并办理签到的， 不得参加本 ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,007,017,588.99, representing a year-on-year increase of 10.73%[3] - The net profit attributable to shareholders was CNY 27,158,710.21, reflecting a growth of 5.48% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 27,232,280.30, which is a significant increase of 103.20% year-on-year[3] - Total operating revenue for Q1 2024 reached ¥1,007,017,588.99, a 10.8% increase from ¥909,421,991.74 in Q1 2023[15] - Net profit for Q1 2024 was ¥34,823,664.69, representing a 28.5% increase compared to ¥27,099,128.83 in Q1 2023[16] - The company’s total profit for Q1 2024 was ¥51,368,322.79, compared to ¥47,006,187.44 in Q1 2023, marking an increase of 7.5%[15] - Basic and diluted earnings per share for Q1 2024 were both ¥0.031, up from ¥0.029 in Q1 2023[16] Cash Flow and Investments - The net cash flow from operating activities decreased by 88.76%, amounting to CNY 22,715,581.99, primarily due to an increase in cash paid for goods and services[5] - The net cash flow from operating activities for Q1 2024 was ¥22,715,581.99, a decrease of 88.8% from ¥202,040,894.22 in Q1 2023[18] - The company reported a net cash outflow from investing activities of ¥53,714,465.67 in Q1 2024, an improvement from a net outflow of ¥124,328,006.74 in Q1 2023[19] - Cash and cash equivalents at the end of Q1 2024 totaled ¥477,036,759.74, down from ¥592,297,013.15 at the end of Q1 2023[19] Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,713,352,483.33, a decrease of 2.18% from the end of the previous year[3] - As of March 31, 2024, the total assets of the company amounted to ¥5,713,352,483.33, a decrease from ¥5,840,942,348.91 as of December 31, 2023, representing a decline of approximately 2.18%[10] - The company's current assets totaled ¥1,000,016,751.61, down from ¥1,084,569,990.04, indicating a decrease of about 7.81%[10] - Total liabilities decreased to ¥2,244,254,495.28 from ¥2,396,247,349.03, a decline of about 6.35%[12] - The company's total equity increased to ¥3,469,097,988.05 from ¥3,444,694,999.88, reflecting a growth of approximately 0.71%[12] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 45,291[7] - The largest shareholder, Jiangsu Wuxi Commercial Building Group Co., Ltd., holds 44.71% of the shares, totaling 395,552,372 shares[7] Other Financial Metrics - The weighted average return on equity was 0.82%, an increase of 0.03 percentage points compared to the previous year[3] - The company reported a non-recurring loss of CNY 73,570.08, primarily due to asset disposal losses and tax impacts[5] - The company’s tax expenses decreased to ¥16,544,658.10 in Q1 2024 from ¥19,907,058.61 in Q1 2023, a reduction of 16.8%[15] - Other comprehensive income after tax for Q1 2024 was -¥423,750.51, a significant decline from ¥8,475,010.20 in Q1 2023[16] Inventory and Receivables - Accounts receivable increased to ¥130,579,327.16 from ¥105,412,811.50, marking an increase of about 23.87%[10] - Inventory decreased to ¥234,915,587.61 from ¥312,724,662.65, a reduction of approximately 24.92%[11] Long-term Investments - The company’s long-term investments in equity stood at ¥2,543,084,593.46, slightly up from ¥2,540,124,938.20, indicating a marginal increase[11] - The company’s total non-current assets amounted to ¥4,713,335,731.71, down from ¥4,756,372,358.87, representing a decrease of approximately 0.90%[11] Product Development and Market Strategy - The company did not report any significant new product developments or market expansion strategies during this quarter[9]

无锡商业大厦大东方股份有限公司 审计报告 2023年度 公证天业会计师事务所(特殊普通合伙) Gongzheng Tianye Certified Public Accountants, SGP 中国 . 江苏 . 无锡 Wuxi . Jiangsu . China 总机：86（510）68798988 Tel：86（510）68798988 传真：86（510）68567788 Fax：86（510）68567788 审计报告 苏公 W[2024]A500 号 无锡商业大厦大东方股份有限公司全体股东： 一、审计意见 我们审计了无锡商业大厦大东方股份有限公司（以下简称大东方股份公司）财 务报表，包括2023年12月31日的合并及母公司资产负债表，2023年度的合并及母公 司利润表、合并及母公司现金流量表、合并及母公司所有者权益变动表以及相关财 务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制，公 允反映了大东方股份公司2023年12月31日的合并及母公司财务状况以及2023年度的 合并及母公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了 ...

Financial Performance - The company achieved operating revenue of 3.53 billion yuan, an increase of 12.91% year-on-year[1]. - Net profit attributable to shareholders was 161 million yuan, a decrease of 8.93% year-on-year[1]. - Operating costs rose to 2.94 billion yuan, reflecting a year-on-year increase of 14.43%[7]. - The net cash flow from operating activities was 367 million yuan, a significant increase of 362.04% compared to the previous year[7]. - The company reported a net profit of approximately ¥163.51 million for the year 2023, with the net profit attributable to shareholders of the listed company being approximately ¥161.46 million[31]. - The basic earnings per share for 2023 was CNY 0.183, down 8.50% from CNY 0.200 in 2022[50]. - The weighted average return on net assets decreased by 0.25 percentage points to 4.84% in 2023 from 5.09% in 2022[50]. - The company reported a significant increase of 32.99% in net profit attributable to shareholders after deducting non-recurring gains and losses, reaching CNY 15,110,226.86 in 2023[50]. - The company's total revenue for the medical health segment in 2023 reached CNY 262,387 million, with a gross profit margin of 6.90%[102]. Cash Flow and Investments - The net cash flow from financing activities turned positive, reaching approximately ¥27.92 million, a significant increase of 106.87% compared to the previous year[22]. - The company’s cash flow from investment activities improved by 36.87% year-on-year, with a net outflow of 344.77 million yuan[7]. - The net cash flow from investing activities improved by 36.87%, amounting to approximately -¥344.77 million, with significant cash inflows from the disposal of subsidiaries and other operating units[22]. - The cash received from the disposal of fixed assets and other long-term assets increased by ¥16.18 million compared to the previous year[22]. - Long-term equity investments increased by RMB 520.95 million compared to the beginning of the year, primarily due to investments in "Jidaohang" and other associated companies[123]. - The company completed a subscription of RMB 595 million for the partnership shares in "Jidaohang" as of December 31, 2023[124]. Operational Efficiency - The company holds a significant proportion of self-owned properties, which helps stabilize operations and reduce long-term operational costs[25]. - The company completed a significant energy-saving project, reducing costs by 76% in the air conditioning system of its office building, enhancing operational efficiency[69]. - The company is implementing a streamlined organizational structure to enhance performance management and operational efficiency across its business units[72]. - The company has established a digital platform to enhance operational efficiency, completing various upgrades and assessments during the reporting period[79]. - The company has focused on risk management by implementing a business risk map and improving internal control measures to mitigate financial risks[78]. Market Expansion and Strategy - The company plans to continue expanding its market presence and enhancing its product offerings in the upcoming fiscal year[32]. - The company expanded its pediatric services, opening 8 new outpatient departments and establishing 2 more under construction, bringing the total operational institutions to 49[64]. - The company aims to enhance its retail business while expanding its healthcare services, positioning itself as a dual-core business in modern consumption and healthcare[184]. - The company plans to improve operational capabilities and revenue structure in its healthcare units, aiming for scale in patient visits and sales revenue[186]. - The company will continue to enhance its Sanfengqiao brand business in 2024, focusing on sales, production capacity, and profitability, with an emphasis on optimizing product quality and gross margin[190]. Risk Management - The company emphasizes the importance of risk management and has detailed potential risks in its annual report[32]. - The company faces macroeconomic risks, including potential declines in consumer confidence and demand due to economic transformation pains and policy uncertainties[191]. - The company acknowledges operational risks related to management and talent development, particularly in the healthcare sector amid tightening national medical insurance funding and increased regulatory scrutiny[193]. Industry Trends - The retail market showed signs of recovery in 2023, with consumption becoming a significant driver of economic recovery, supported by various consumer policies[128]. - The aging population in China is projected to increase by 12.9% over the next decade, leading to significant growth pressure on medical demand[139]. - The market for children's medical services is projected to exceed 15 trillion yuan, driven by a large base of 298 million children aged 0-17 in China[148]. - The condiment and marinated food market is projected to reach ¥224 billion in 2023, with a CAGR of 9.56% from 2018 to 2023 despite pandemic pressures[169]. Corporate Governance - The company has established a comprehensive corporate governance structure to ensure compliance with legal regulations and protect shareholder rights[198]. - The company emphasizes transparency in information disclosure, ensuring timely and accurate communication with stakeholders[198]. - The company is focused on continuous improvement of its governance mechanisms to support stable and healthy development[198].

无锡商业大厦大东方股份有限公司 2023 年度社会责任报告 2024 年 4 月 18 日 1 | 前 言 4 | | | --- | --- | | 第一章 公司情况概述 5 | | | 一、 公司介绍 5 | | | 二、 公司组织架构 | 5 | | 三、 公司文化 6 | | | 第二章 股东和债权人权益保护 | 7 | | 一、 规范公司治理 | 7 | | 二、 认真履行信息披露义务，确保信息真实准确 7 | | | 三、 加强投资者关系管理 | 7 | | 四、 加强内控制度建设，切实防范经营风险 | 8 | | 五、 积极构建与股东的和谐关系，重视股东回报 8 | | | 六、 注重发展银企合作关系，致力于建设多元化融资体系 | 8 | | 第三章 员工权益保护 9 | | | 一、 参与管理，充分发挥工会组织在企业民主管理、民主监督中的组织参与作用 | 9 | | 1、建立健全集体合同协商制度，完善企业劳动保障体系 | 9 | | 2、坚持和完善以职工代表大会为基本形式的企业民主管理 9 | | | 二、 心怀员工，充分发挥工会组织在企业文化建设中的凝聚作用 | 9 | | 1、扶危济困，建 ...